FTO Obesity Variant Circuitry and Adipocyte Browning in Humans by Claussnitzer, Melina et al.
The new england  
journal of medicine
n engl j med 373;10 nejm.org September 3, 2015 895
established in 1812 September 3, 2015 vol. 373 no. 10
The authors’ affiliations are listed in the 
Appendix. Address reprint requests to Dr. 
Claussnitzer at the Gerontology Division, 
Beth Israel Deaconess Medical Center 
and Hebrew SeniorLife, Harvard Medical 
School, 1200 Centre St., Boston, MA 
02215, or at  melina@ broadinstitute . org; 
or to Dr. Kellis at the Computer Science 
and Artificial Intelligence Laboratory, MIT, 
32 Vassar St., Cambridge, MA 02139, or 
at  manoli@ mit . edu.
Drs. Dankel and Kim contributed equally 
to this article.
This article was published on August 19, 
2015, at NEJM.org.
N Engl J Med 2015;373:895-907.
DOI: 10.1056/NEJMoa1502214
Copyright © 2015 Massachusetts Medical Society.
BACKGROUND
Genomewide association studies can be used to identify disease-relevant genomic 
regions, but interpretation of the data is challenging. The FTO region harbors the 
strongest genetic association with obesity, yet the mechanistic basis of this asso-
ciation remains elusive.
METHODS
We examined epigenomic data, allelic activity, motif conservation, regulator ex-
pression, and gene coexpression patterns, with the aim of dissecting the regula-
tory circuitry and mechanistic basis of the association between the FTO region and 
obesity. We validated our predictions with the use of directed perturbations in 
samples from patients and from mice and with endogenous CRISPR–Cas9 genome 
editing in samples from patients.
RESULTS
Our data indicate that the FTO allele associated with obesity represses mitochon-
drial thermogenesis in adipocyte precursor cells in a tissue-autonomous manner. 
The rs1421085 T-to-C single-nucleotide variant disrupts a conserved motif for the 
ARID5B repressor, which leads to derepression of a potent preadipocyte enhancer 
and a doubling of IRX3 and IRX5 expression during early adipocyte differentiation. 
This results in a cell-autonomous developmental shift from energy-dissipating 
beige (brite) adipocytes to energy-storing white adipocytes, with a reduction in 
mitochondrial thermogenesis by a factor of 5, as well as an increase in lipid stor-
age. Inhibition of Irx3 in adipose tissue in mice reduced body weight and increased 
energy dissipation without a change in physical activity or appetite. Knockdown of 
IRX3 or IRX5 in primary adipocytes from participants with the risk allele restored 
thermogenesis, increasing it by a factor of 7, and overexpression of these genes 
had the opposite effect in adipocytes from nonrisk-allele carriers. Repair of the 
ARID5B motif by CRISPR–Cas9 editing of rs1421085 in primary adipocytes from 
a patient with the risk allele restored IRX3 and IRX5 repression, activated browning 
expression programs, and restored thermogenesis, increasing it by a factor of 7.
CONCLUSIONS
Our results point to a pathway for adipocyte thermogenesis regulation involving 
ARID5B, rs1421085, IRX3, and IRX5, which, when manipulated, had pronounced 
pro-obesity and anti-obesity effects. (Funded by the German Research Center for 
Environmental Health and others.)
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Obesity affects more than 500 mil-lion people worldwide and contributes to type 2 diabetes, cardiovascular disorders, 
and cancer.1 Obesity is the result of a positive 
energy balance, whereby energy intake exceeds 
expenditure, resulting in the storage of energy, 
primarily as lipids in white adipocytes. Energy 
balance is modulated by food consumption and 
physical activity, as well as by the dissipation of 
energy as heat through constitutive thermogen-
esis in mitochondria-rich brown adipocytes in 
brown fat and through inducible thermogenesis 
in beige adipocytes in white fat.2-6 Thermogene-
sis is triggered by mechanisms within the cells 
themselves or by the sympathetic nervous system 
(e.g., through β-adrenergic receptor agonists), in 
response to exercise, diet, or exposure to cold. 
Regulators of mitochondrial thermogenesis (in-
cluding IRF4, PGC1α, PRDM16, and TBX15) 
control the expression of the gene encoding 
uncoupling protein 1 (UCP1),4,7-9 which depolar-
izes the inner mitochondrial membrane, causing 
proton transfer and heat dissipation.
Body-mass index (BMI) has a strong genetic 
component (40 to 80% heritability) involving 
several genes that have expression in the hypo-
thalamus and fulfill roles in appetite regula-
tion.10,11 The strongest genomewide association 
signal lies in introns 1 and 2 of the gene FTO12,13; 
this region contains 89 common variants 
(Fig. 1A) that are in high linkage disequilibrium 
in Europeans (r2≥0.8)12,13 across approximately 
47,000 nucleotides, which makes the identifica-
tion of the likely causal variant challenging. The 
associated region lacks protein-altering variants, 
which has prompted numerous gene-regulatory 
studies17-21; these studies have predicted diverse 
and conflicting target genes and tissues, includ-
ing FTO itself in a whole-body knockout,17 IRX3 
in pancreas20 or brain,19 RBL2 in lymphocytes,21 
and RPGRIP1L in brain.18 However, the identifica-
tion of a mechanistic basis for the association 
between the FTO locus and obesity in humans 
has been elusive, the relevant cell types and tar-
get genes remain unresolved, and the causal 
variant remains uncharacterized. In this study, 
we sought to identify a causal variant with regu-
latory roles, its upstream regulator, and its 
downstream target gene in order to provide a 
candidate mechanistic basis for the association 
between FTO and obesity.
Me thods
Participants
Primary human adipose–derived progenitor cell 
cultures were obtained from the subcutaneous 
adipose tissue of 100 healthy Europeans who 
were 20 to 50 years of age and had a BMI (the 
weight in kilograms divided by the square of the 
height in meters) of 20 to 24, which was in the 
normal range. The sample included 52 partici-
pants (hereafter referred to as risk-allele carriers) 
who were homozygous for the risk allele for the 
tag variant rs9930506 (which has been reported 
in genomewide association studies), as well as for 
the associated variants rs1421085 and rs1558902; 
together, these variants make up part of the risk 
haplotype, which in its entirety includes 89 vari-
ants in introns 1 and 2 of FTO that are common 
in European populations. The sample also includ-
ed 48 participants who were homozygous for the 
nonrisk allele for all three of these variants 
(hereafter referred to as nonrisk-allele carriers). 
Primary cell cultures were used for the preparation 
of mitochondrial and nuclear messenger RNA, 
quantitative polymerase-chain-reaction (PCR) 
gene-expression analysis, assays of mitochon-
drial function and thermogenesis, determination 
of lipolysis rates, small interfering RNA–mediated 
knockdown, doxycycline-mediated overexpression, 
and CRISPR–Cas9 genome editing. In addition, 
whole adipose tissue and adipose-derived progeni-
tor cells were obtained and RNA was isolated 
from a second European cohort of nongenotyped 
participants, including 12 severely obese patients 
(BMI, 35 to 52) who were undergoing bariatric 
surgery and 22 healthy nonobese participants 
(BMI, 18 to 28) who were undergoing elective 
surgery. We received approval from the local ethics 
committees in Germany, Norway, and Sweden. 
All participants gave written informed consent.
Study Design
We used techniques of epigenomics, compara-
tive genomics, human genetics, genome editing, 
and directed perturbations in samples from pa-
tients and from mice to dissect the regulatory 
circuitry and mechanistic basis of the FTO obe-
sity-associated locus. Our methods are described 
in detail in the Methods section in the Supple-
mentary Appendix, available with the full text of 
this article at NEJM.org.
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On the basis of epigenomic annotations 
across 127 human cell types, we predicted the 
cell type in which the genetic variant was likely 
to act, and we validated the prediction with the 
use of haplotype-specific enhancer assays. We 
analyzed long-range chromatin interactions in 
the region surrounding FTO to define potential 
target genes, and to validate genetic targets, we 
conducted an expression quantitative-trait-locus 
(eQTL) analysis in primary human adipocytes 
from risk-allele carriers and nonrisk-allele carri-
ers. We predicted the cellular processes affected 
by the obesity-associated variants on the basis of 
correlated expression with the target genes 
across participants, and we validated their genetic 
control with the use of a trans-eQTL analysis 
of energy-balance genes (i.e., an eQTL analysis of 
energy-balance genes at large genomic distances 
from the FTO locus) in adipocytes, as well as by 
measuring cellular phenotypes in risk-allele car-
riers and nonrisk-allele carriers. To examine the 
causal roles for the predicted target genes, we 
first used knockdown and overexpression of each 
target gene in primary human adipocytes from 
the subcutaneous fat of risk-allele carriers and 
nonrisk-allele carriers, followed by cellular pheno-
typing; second, we used generation of mice with 
a dominant negative allele of one of the target 
genes expressed in adipose tissue, followed by 
organism-level phenotyping, histologic measure-
ments, and gene-expression profiling in major 
fat stores; and third, we used knockdown, over-
expression, and knockout in three mouse adipo-
cyte models.
We predicted the single-nucleotide variant 
(SNV) responsible for dysregulation of the target 
genes on the basis of a quantitative analysis of 
regulatory-motif conservation, and we used ex-
perimental alterations of the predicted causal 
nucleotide to validate its causality for enhancer 
activity and regulator binding. To predict the 
upstream regulator, we examined regulatory 
motif matches and regulator expression levels in 
adipocytes from obese and nonobese participants; 
we then experimentally validated its causality 
and epistasis with the risk haplotype by means 
of knockdown and overexpression in adipocytes 
from risk-allele carriers and nonrisk-allele carri-
ers. Finally, we established the cell-autonomous 
causality of the predicted driver variant with the 
use of bidirectional CRISPR–Cas9 editing in pri-
Figure 1. Activation of a Superenhancer in Human Adipocyte Progenitors by 
the FTO Obesity Risk Haplotype.
Panel A shows the genetic association with body‑mass index (BMI) for all 
common FTO locus variants,14 including the reported single‑nucleotide 
variant (SNV) rs1558902 (red diamond) and the predicted causal SNV 
rs1421085 (red square). Gray shading delineates consecutive 10‑kb segments. 
CEU denotes a population of Utah residents with northern and western Eu‑
ropean ancestry, and LD linkage disequilibrium. Panel B shows chromatin 
state annotations for the locus across 127 reference epigenomes (rows) for 
cell and tissue types profiled by the Roadmap Epigenomics Project.15,16 For 
information on the colors used to denote chromatin states, see Figure S1A 
in the Supplementary Appendix. Vertical lines delineate the consecutive  
10‑kb segments shown in Panel A. ESC denotes embryonic stem cell, HSC 
hematopoietic stem cell, and iPSC induced pluripotent stem cell. Panel C 
shows human SGBS adipocyte enhancer activity, for 10‑kb tiles, of the risk 
and nonrisk haplotypes with the use of relative luciferase expression. The 
boxes indicate means from seven triplicate experiments, and T bars indicate 
standard deviations.
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mary adipocytes from risk-allele carriers and 
nonrisk-allele carriers, followed by measurement 
of target-gene expression, expression levels of 
energy-balance genes, and cellular phenotypic 
signatures of obesity in humans. Additional in-
formation on our methods is provided in the 
protocol (available at NEJM.org) and in the 
Supplementary Appendix.
R esult s
Effect of the FTO Locus on IRX3 and IRX5  
in Human Adipocyte Progenitor Cells
To identify the cell types in which the causal 
variant may act, we examined chromatin state 
maps15,16 of the FTO obesity region across 127 
cell types. An unusually long enhancer (12.8 kb) 
in mesenchymal adipocyte progenitors indicated 
a major regulatory locus (Fig. 1B; and Fig. S1A, 
S1B, and S1C in the Supplementary Appendix). 
Haplotype-specific enhancer assays showed ac-
tivity in association with the risk haplotype that 
was 2.4 times as high as that associated with the 
nonrisk haplotype in human SGBS adipocytes 
(i.e., adipocytes derived from a patient with the 
Simpson–Golabi–Behmel syndrome), which indi-
cated genetic control of enhancer activity (Fig. 1C). 
Enhancers in brain cells and other cell types 
were considerably shorter than those in mesen-
chymal adipocyte progenitors and lacked allelic 
activity (Fig. S1C and S1D in the Supplementary 
Appendix).
To predict putative target genes, we examined 
large domains that had long-range three-dimen-
sional chromatin interactions surrounding FTO 
and identified eight candidate genes (Fig. 2A 
and 2B). Among them, the developmental regu-
lators IRX3 and IRX5 had genotype-associated 
expression, which indicated long-range (1.2-Mb) 
genetic control in primary preadipocytes (Fig. 2C). 
Genotype-associated expression was not ob-
served in whole-adipose tissue, a finding consis-
tent with previous reports23,24; this indicated that 
the effect was cell type–specific and restricted to 
preadipocytes, which represent a minority of 
cells in adipose tissue (Fig. S2A in the Supple-
mentary Appendix).
Effect of the FTO Locus on Mitochondrial 
Thermogenesis and Lipid Storage
To identify the biologic processes affected by 
altered IRX3 and IRX5 expression in adipocytes, 
we used genomewide expression patterns in 
brown adipocyte–containing perirenal adipose 
tissue from a separate cohort of 10 nongeno-
typed, healthy kidney donors to identify genes 
with expression that was positively or negatively 
correlated with IRX3 and IRX5 expression. Genes 
that are associated with mitochondrial functions 
were found to have a negative correlation with 
IRX3 and IRX5, and genes with FXR and RXR 
lipid-metabolism functions were found to have a 
positive correlation, which suggests that IRX3 and 
IRX5 may play roles in energy dissipation and 
storage (Fig. 3A, and Table S1 in the Supplemen-
tary Appendix). IRX3 and IRX5 had consistently 
higher mean expression in white adipose tissue 
from nine participants, as well as negative cor-
relation with PGC1A and UCP1 expression, as as-
sessed with the use of interindividual expression 
patterns in perithyroid brown adipose tissue 
(Fig. S2B and S2C in the Supplementary Appen-
dix); these findings indicated potential roles for 
IRX3 and IRX5 in the repression of thermogenesis.
To examine the trans-eQTL genetic control of 
energy balance by the FTO obesity locus, we used 
primary preadipocytes from risk-allele carriers 
and nonrisk-allele carriers to evaluate the genes 
with mitochondrial and FXR and RXR functions 
that had expression patterns most closely corre-
lated with those of IRX3 and IRX5, as well as 
several known markers of energy-balance regu-
lation (Fig. S2D and S2E in the Supplementary 
Appendix). As compared with nonrisk-allele car-
riers, risk-allele carriers had lower expression of 
mitochondrial, browning, and respiration genes 
and higher expression of lipid-storage markers, 
which indicated a shift from energy dissipation 
to energy storage.
These differences in expression were also re-
flected in the cellular signatures of obesity. Risk-
allele carriers had increased adipocyte size, re-
duced mitochondrial DNA content, and a loss of 
UCP1 response to β-adrenergic stimulus or cold 
exposure (Fig. 3B and 3C, and Fig. S2F in the 
Supplementary Appendix), as well as resistance 
to isoproterenol-mediated uncoupling, a de-
creased basal oxygen consumption rate, and a 
reduction in mitochondrial thermogenesis by a 
factor of 5 (Fig. S2G in the Supplementary Ap-
pendix); this indicated excessive accumulation of 
triglycerides, reduced mitochondrial oxidative 
capacity, reduced white adipocyte browning, and 
reduced thermogenesis.
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 Adipocyte-Autonomous Effects of IRX3 
and IRX5 on Energy Balance
We next quantified the effect that manipulation 
of IRX3 and IRX5 expression had on thermogen-
esis in primary preadipocytes that were isolated 
from both risk-allele carriers and nonrisk-allele 
carriers. In preadipocytes from risk-allele carri-
ers, IRX3 and IRX5 knockdown restored oxygen 
consumption and thermogenesis response to 
nonrisk levels, increased thermogenesis by a fac-
tor of 7 (Fig. 3D), and restored UCP1 expression 
levels (Fig. S3A in the Supplementary Appendix). 
In preadipocytes from nonrisk-allele carriers, 
IRX3 and IRX5 overexpression reduced basal res-
piration and thermogenesis to risk-allele levels 
(with thermogenesis reduced by a factor of 8) 
(Fig. 3D) and decreased the expression of UCP1, 
other regulators of mitochondrial function and 
Figure 2. Activation of IRX3 and IRX5 Expression in Human Adipocyte Progenitors by the FTO Obesity Risk Genotype.
Panel A shows gene annotations and LD with array tag variant rs9930506 in a 2.5‑Mb window; LD is expressed as r2 
values in the CEU population. Arrows indicate the direction of transcription of annotated genes in the locus. Panel B 
shows chromosome conformation capture (Hi‑C) interactions contact probabilities in human IMR90 myofibro‑
blasts,22 revealing a 2‑Mb topologically associating domain, and LD mean r2 statistics for all SNV pairs at 40‑kb res‑
olution. Panel C shows box plots for expression levels, after 2 days of differentiation, in human adipose progenitors 
isolated from 20 risk‑allele carriers and 18 nonrisk‑allele carriers, evaluated by means of a quantitative polymerase‑
chain‑reaction analysis for all genes in the 2.5‑Mb locus. The horizontal line within each box represents the median, 
the top and bottom of each box indicate the 75th and 25th percentile, and I bars indicate the range.
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thermogenesis (PGC1A, PGC1B, and PRDM16), 
and the β-adrenergic receptor (ADRB3), which 
also regulates UCP1-independent thermogenesis 
programs (Fig. S3B and S3C in the Supplemen-
tary Appendix). These manipulations had no 
significant effect on preadipocytes from partici-
pants with the reciprocal genotypes, which indi-
cated that IRX3 and IRX5 levels recapitulate the 
effect that the FTO genetic variant has on thermo-
genesis.
To examine the organism-level effects of the 
repression of Irx3 in adipose tissue, we used 
adipose Irx3 dominant-negative (aP2-Irx3DN) 
mice. These mice had pronounced antiobesity 
characteristics, including reduced body size, 
body weight, fat mass, white and brown fat de-
pots, and adipocyte size (Fig. S4A through S4G 
in the Supplementary Appendix). These aP2-Irx-
3DN mice also had resistance to weight gain on 
a high-fat diet, increased energy expenditure 
both at night and during the day, and increased 
oxygen consumption both at room temperature 
(22°C) and in thermoneutral conditions (30°C), 
but they did not have significant differences 
from control mice in food intake or locomotor 
activity (Fig. S4A and S4H through S4L in the 
Supplementary Appendix). At the molecular and 
cellular levels, these mice had increased mito-
chondrial activity and thermogenesis marker ex-
pression, reduced lipid-storage marker expression 
in both white and brown fat compartments, and 
markedly smaller adipocytes than did control 
mice (Fig. S4M, S4N, and S4O in the Supplemen-
tary Appendix).
We next evaluated the tissue-autonomous 
versus brain-mediated roles of Irx3 by comparing 
the aP2-Irx3DN mice with hypothalamus domi-
nant-negative Ins2-Irx3DN mice.19 The aP2-Irx-
3DN mice had a reduction in fat-mass ratio that 
was 3 times as great as that in Ins2-Irx3DN mice 
(a reduction of 57% vs. 19%), despite the fact 
that transgene expression in the hypothalamus 
was 3 times lower than that in Ins2-Irx3DN mice 
(Fig. S4P and S4Q in the Supplementary Appen-
dix), which indicated that Irx3 has a hypothala-
mus-independent regulatory role in whole-body 
energy regulation. The phenotypic effects of Irx3 
repression in aP2-Irx3DN mice were also stron-
ger than those in whole-body Irx3 knockout 
mice, which suggested potential dominant re-
pressor effects in adipocytes or other tissues, 
and were independent of Fto gene expression, 
which did not change (Fig. S4P and S4R in the 
Supplementary Appendix).
Our findings indicate that both Irx3 and Irx5 
have cell-autonomous roles: manipulation of Irx3 
and Irx5 led to energy-balance differences in 
three mouse cellular models, including mouse 
embryonic fibroblast–derived adipocytes, white 
3T3-L1 preadipocytes, and β-adrenergic–stimu-
lated beige ME3 preadipocytes (Fig. S5 in the 
Supplementary Appendix). In each case, our re-
sults indicated that Irx3 and Irx5 induced adipo-
cyte lipid accumulation and repressed thermo-
genesis in a cell-autonomous way.
Determination of the Causal Variant  
and Disruption of Repression by ARID5B
To predict the causal variant, the disruption of 
which is necessary and sufficient to cause IRX3 
and IRX5 dysregulation in human preadipocytes, 
we used phylogenetic module complexity analy-
sis (PMCA)25 (Fig. 4A and 4B, and Fig. S6A and 
S6B in the Supplementary Appendix). The highest 
PMCA score was found for the rs1421085 T-to-C 
SNV, which is in perfect linkage disequilibrium 
with the most significant reported SNV, rs1558902, 
across multiple populations (1000 Genomes 
Phase 1 data), a finding that is consistent with a 
potentially causal role.
To evaluate whether rs1421085 plays a causal 
Figure 3 (facing page). Regulation of Obesity-Associated 
Cellular Phenotypes in Human Adipocytes by IRX3  
and IRX5.
Panel A shows the mitochondrial and FXR and RXR ac‑
tivation genes with strongest positive (in red) or nega‑
tive (in green) correlation with IRX3 and IRX5 in human 
perirenal adipose tissue from 10 participants. Panels B 
and C show box plots of the increased adipocyte diam‑
eter and decreased mitochondrial DNA content in iso‑
lated differentiated adipocytes from risk‑allele carriers 
(16 and 8 participants, respectively) relative to nonrisk‑
allele carriers (26 and 8, respectively). The vertical line 
within each box represents the median, the left and 
right margins of each box indicate the interquartile 
range, and I bars indicate the range. Panel D shows box 
plots of the altered basal and isoproterenol‑stimulated 
oxygen consumption rate (OCR) on small interfering 
RNA (siRNA) knockdown and doxycycline (DOX)–medi‑
ated overexpression of IRX3 and IRX5 in 8 risk‑allele 
carriers and 10 nonrisk‑allele carriers. The siRNA effi‑
ciency was 62% for IRX3 and 71% for IRX5. The hori‑
zontal line within each box represents the median, the 
top and bottom of each box indicate the interquartile 
range, and I bars indicate the range.
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role in enhancer activity, we introduced the C 
allele into the nonrisk haplotype in our lucifer-
ase reporter assay. The T-to-C single-nucleotide 
alteration increased enhancer activity levels for 
10-kb and 1-kb segments centered on the vari-
ant, in both orientations and both upstream and 
downstream of the transcription start, which in-
dicated a gain of enhancer activity in association 
with the rs1421085 risk allele (Fig. S6C and S6D 
in the Supplementary Appendix).
To evaluate the effect of the variant on regula-
tor binding, we used electrophoretic mobility-
shift assays (EMSAs) of adipocyte nuclear extract 
with probes for the risk allele and the nonrisk 
allele of rs1421085. We found binding for the non-
risk allele, T, which lacked enhancer activity, but 
no binding for the risk allele, C; this indicated 
that the increased enhancer activity associated 
with the risk allele is probably due to a loss of re-
pressor binding rather than to a gain of activator 
binding (Fig. S6E in the Supplementary Appendix).
We examined disrupted motifs and regulator 
expression to identify potential upstream regula-
tors. The T-to-C substitution disrupted conserved 
motifs for NKX6-3, LHX6, and the ARID family 
of regulators (Fig. 4A). Among them, ARID5B 
had the highest expression in adipose tissue and 
adipocytes and was bound specifically to the 
nonrisk allele in EMSA competition experiments 
(Fig. S6E and S6F in the Supplementary Appen-
dix). ARID5B is known to play both repressive 
and activating roles and was previously impli-
cated in adipogenesis and lipid metabolism in 
mice.27,28. Among nonrisk-allele carriers, expres-
sion of ARID5B was negatively correlated with 
expression of IRX3 and IRX5, a finding consis-
tent with ARID5B having a repressive role. No 
correlation was found in risk-allele carriers, 
which indicates a loss of ARID5B regulation 
(Fig. S6G in the Supplementary Appendix).
To evaluate the causal role of ARID5B, we 
next examined the effects of its knockdown and 
overexpression on IRX3 and IRX5. ARID5B knock-
down increased IRX3 and IRX5 expression in 
primary preadipocytes from nonrisk-allele carri-
ers to risk-allele levels, which indicates a loss of 
repression, but it had no effect on preadipocytes 
from risk-allele carriers, which indicates epista-
sis with the obesity-risk haplotype (Fig. S6H in 
the Supplementary Appendix). Consistent with 
this finding, in SGBS enhancer assays, ARID5B 
knockdown increased the activity of preadipocytes 
with the nonrisk allele to risk-allele levels, which 
indicates a loss of repression, but had no effect 
on risk-allele constructs, indicating epistasis with 
the rs1421085 risk allele (Fig. S6I in the Supple-
mentary Appendix). ARID5B overexpression fur-
ther reduced IRX3 and IRX5 levels in nonrisk-al-
lele carriers, which indicated that repression was 
strengthened, but had no significant effect on 
risk-allele carriers, a finding consistent with 
impaired ARID5B repression in association with 
the risk haplotype (Fig. S6J in the Supplementary 
Appendix).
We also evaluated the cellular effects of 
ARID5B-directed perturbations in primary pre-
adipocytes from risk-allele carriers and nonrisk-
allele carriers. In preadipocytes from nonrisk-
allele carriers, ARID5B knockdown reduced basal 
oxygen consumption and lipolysis (Fig. S6K and 
S6L in the Supplementary Appendix) and shifted 
expression patterns from mitochondrial to lipid 
markers (Fig. S2E in the Supplementary Appen-
dix), which indicated that ARID5B plays causal 
roles in energy-balance regulation. In contrast, 
ARID5B knockdown had no effect on preadipo-
cytes from risk-allele carriers, a finding consis-
tent with a loss of ARID5B control.
These results suggest that the FTO obesity 
variant acts through disruption of ARID5B bind-
ing in the risk haplotype, leading to a loss of 
repression, a gain of enhancer activity, and in-
creases in IRX3 and IRX5 expression (Fig. S6M in 
the Supplementary Appendix).
C-to-T Editing of the rs1421085 Risk Variant 
and the Effect on Thermogenesis
Targeted genome editing technology involving 
CRISPR–Cas929 makes it possible to test the phe-
notypic effect of altering the predicted causal 
nucleotide rs1421085 in its endogenous genomic 
context, in isolation from the other obesity-asso-
ciated genetic variants in the same haplotype. 
We used CRISPR–Cas9 in primary preadipocytes 
with two separate guide RNAs, one for rs1421085 
C-to-T rescue of the ARID5B motif disruption in 
risk-allele carriers and one for rs1421085 T-to-C 
disruption of the ARID5B motif in nonrisk-allele 
carriers.
We first evaluated the effect of rs1421085 
editing on IRX3 and IRX5 expression levels. 
Starting from preadipocytes of a nonrisk-allele 
carrier, T-to-C editing doubled endogenous IRX3 
and IRX5 expression, to levels seen in risk-allele 
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carriers; starting from the edited preadipocytes, 
C-to-T re-editing back to the nonrisk allele re-
stored low expression levels (Fig. 4C). Starting 
from the risk haplotype, C-to-T editing reduced 
IRX3 and IRX5 to nonrisk-allele levels, but only 
in the presence of ARID5B (Fig. 4D); this estab-
lished that disruption of ARID5B repression by 
rs1421085 is the mechanistic basis of the IRX3 
and IRX5 dysregulatory event that mediates the 
effects of the FTO locus on obesity.
Next, we evaluated the role of rs1421085 edit-
ing during differentiation of white and beige 
adipocytes, by studying differences in expression 
between edited and unedited preadipocytes dur-
ing differentiation. Unedited adipocytes from a 
risk-allele carrier had a peak in IRX3 and IRX5 
expression during days 0 and 2 of preadipocyte 
differentiation into adipocytes; expression dur-
ing early differentiation was reduced to nonrisk-
allele levels by rs1421085 editing, which indi-
cated a causal role of rs1421085 in developmental 
gene expression programs (Fig. 5A). The causal 
role of rs1421085 was further reflected in a sig-
nificant increase in the expression of thermo-
genesis regulators (ADRB3, DIO2, PGC1A, and 
UCP1) and mitochondrial markers (NDUFA10, 
COX7A, and CPT1) in differentiating preadipo-
cytes (Fig. 5B), which indicated that C-to-T edit-
ing of the risk allele rescued thermogenesis 
regulatory programs.
Last, we evaluated the role of rs1421085 edit-
ing in cellular signatures of obesity by quantify-
ing phenotypic differences between edited and 
unedited adipocytes. A causal role in the regula-
tion of energy balance was indicated by the fact 
that C-to-T rescue of rs1421085 in edited adipo-
cytes resulted in a reduction in gene expression 
for lipid storage and lipolytic markers (Fig. S2E 
and S8A in the Supplementary Appendix), an 
increase by a factor of 4 in basal metabolic rate 
and β-adrenergic oxygen consumption, and an 
increase by a factor of 7 in thermogenesis 
(Fig. 5C, and Fig. S7B in the Supplementary Ap-
pendix). In particular, rescue of the ARID5B 
motif in C-to-T edited preadipocytes restored the 
strong dependence of mitochondrial respiration 
on ARID5B that is seen in nonrisk-allele carriers 
(Fig. S7C in the Supplementary Appendix).
These results indicate that the rs1421085 T-
to-C single-nucleotide alteration underlies the 
association between FTO and obesity by disrupt-
ing ARID5B-mediated repression of IRX3 and 
IRX5. This disruption leads to a developmental 
shift from browning to whitening programs and 
loss of mitochondrial thermogenesis (Fig. 5D).
Discussion
Our work elucidates a potential mechanistic ba-
sis for the genetic association between FTO and 
obesity and indicates that the causal variant 
rs1421085 can disrupt ARID5B repressor bind-
ing; this disruption results in derepression of 
IRX3 and IRX5 during early adipocyte differen-
tiation. This process could lead to a cell-autono-
mous shift from white adipocyte browning and 
thermogenesis to lipid storage, increased fat 
stores, and body-weight gain.
To translate the results of genomewide asso-
ciation studies into mechanistic insights, we 
combined public resources (epigenomic annota-
tions, chromosome conformation, and regula-
tory motif conservation), targeted experiments 
for risk and nonrisk haplotypes (enhancer tiling, 
gene expression, and cellular profiling), and di-
rected perturbations in human primary cells and 
mouse models (regulator–target knockdown and 
overexpression and CRISPR–Cas9 genome edit-
ing). These methods are specific to the elucida-
tion of noncoding variants, which constitute the 
majority of signals in genomewide association 
Figure 5 (facing page). Rescue of Metabolic Effects  
on Adipocyte Thermogenesis through Editing of SNV 
rs1421085 in a Risk-Allele Carrier.
Panel A shows increased mean expression of IRX3 and 
IRX5 during early adipocyte differentiation specifically 
for the risk allele; increased expression levels are res‑
cued by C‑to‑T genome editing. I bars indicate standard 
deviations. Panel B shows increased expression of ther‑
mogenic and mitochondrial genes on C‑to‑T endogenous 
single‑nucleotide editing of rs1421085 in adipocyte pro‑
genitors from a patient with the risk allele. Panel C shows 
increased basal and isoproterenol‑stimulated OCR on 
C‑to‑T single‑nucleotide endogenous rescue of rs1421085 
in adipocytes from a risk‑allele carrier. Panel D shows 
a summary of our mechanistic model of the FTO locus 
association with obesity, implicating a developmental 
shift favoring lipid‑storing white adipocytes over energy‑
burning beige adipocytes. At its core lies a single‑ 
nucleotide T‑to‑C variant, rs1421085, which disrupts  
a conserved ARID5B repressor motif and activates a 
mesenchymal superenhancer and its targets (IRX3 and 
IRX5), leading to reduced heat dissipation by mitochon‑
drial thermogenesis (a process that is regulated by UCP1, 
PGC1α, and PRDM16) and to increased lipid storage in 
white adipocytes.
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studies; 80% of the trait-associated loci identi-
fied in such studies lack protein-altering vari-
ants, and 93% of the top hits are noncoding.30
The FTO association with obesity is unusual 
in many ways. First, rs1421085 has both a high 
frequency and a strong effect size,31 which sug-
gests positive selection or bottlenecks (e.g., 44% 
frequency in European populations vs. 5% in 
African populations). Second, rs1421085 has 
switchlike behavior in enhancer activity, target-
gene expression, and cellular phenotypes, pos-
sibly because of selective pressures on energy-
balance control for rapid adaptation. Third, 
rs1421085 acts specifically in the early differen-
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tiation of preadipocytes, which emphasizes the 
importance of profiling diverse tissues, cell 
types, and developmental stages. Fourth, enhanc-
er activity is found only for the risk allele, which 
emphasizes the importance of profiling both 
alleles. Finally, rs1421085 leads to a gain of func-
tion (increased enhancer, IRX3, and IRX5 activ-
ity); this is a rare property in protein-coding vari-
ants but may be common in noncoding variants.
The apparent genetic link between obesity 
and cell-autonomous adipocyte browning sug-
gests a central role of beige adipocyte thermo-
genesis in whole-body energy metabolism in 
humans, a role that is consistent with that sug-
gested in recent reports on PRDM16 in mice.9 
IRX3 and IRX5 have evolutionarily conserved 
roles, and the ARID5B motif lies in a module 
that is functionally conserved across multiple 
mammalian species; this indicates that adaptive 
thermogenesis circuits are conserved, and IRX3 
and IRX5 probably play both UCP1-dependent 
and UCP1-independent roles. Even though IRX3 
and IRX5 dysregulation by rs1421085 was re-
stricted to early differentiation, their effects 
persisted in mature adipocytes, and the target-
ing of these genes can have broader effects.
Last, we found that direct manipulation of 
the ARID5B–rs1421085–IRX3/IRX5 regulatory 
axis in primary cell cultures of adipocytes from 
patients reversed the signatures of obesity. This 
indicates that in addition to changes in physical 
activity and nutrition, manipulation of mito-
chondrial thermogenesis26 offers a potential 
third pathway for shifting between energy stor-
age and expenditure in a brain-independent and 
tissue-autonomous way in humans.
In summary, our work elucidates a mechanis-
tic basis for the strongest genetic association 
with obesity. Our results indicate that the SNV 
rs1421085 underlies the genetic association be-
tween the FTO locus and obesity. The SNV dis-
rupts an evolutionarily conserved motif for the 
ARID5B repressor, which leads to loss of bind-
ing, derepression of a potent preadipocyte super-
enhancer, and activation of downstream targets 
IRX3 and IRX5 during early differentiation of 
mesenchymal progenitors into adipocyte sub-
types. This results in a cell-autonomous shift 
from white adipocyte browning to lipid-storage 
gene expression programs and to repression of 
basal mitochondrial respiration, a decrease in 
thermogenesis in response to stimulus, and an 
increase in adipocyte size. Manipulation of the 
uncovered pathway, including knockdown or 
overexpression of the upstream regulator 
ARID5B, genome editing of the predicted causal 
variant rs1421085, and knockdown or overex-
pression of target genes IRX3 and IRX5, had a 
significant effect on obesity phenotypes.
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